| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.90e-09 | 11 | 108 | 5 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 3.42e-08 | 18 | 108 | 5 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.62e-08 | 19 | 108 | 5 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.03e-07 | 22 | 108 | 5 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 7.36e-06 | 50 | 108 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.91e-06 | 24 | 108 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.41e-05 | 57 | 108 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.82e-05 | 60 | 108 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.69e-05 | 65 | 108 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.69e-05 | 65 | 108 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.39e-05 | 75 | 108 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 6.11e-05 | 77 | 108 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.04e-04 | 86 | 108 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.11e-04 | 100 | 108 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.42e-04 | 103 | 108 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.50e-04 | 320 | 108 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.65e-04 | 26 | 108 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 3.96e-04 | 326 | 108 | 8 | GO:0001217 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.91e-04 | 125 | 108 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.38e-03 | 151 | 108 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.17e-03 | 13 | 108 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.38e-03 | 171 | 108 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 2.53e-03 | 14 | 108 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.53e-03 | 14 | 108 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.80e-03 | 52 | 108 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 2.91e-03 | 15 | 108 | 2 | GO:0005005 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 5.04e-07 | 30 | 110 | 5 | GO:1904862 | |
| GeneOntologyBiologicalProcess | synapse organization | LGMN FRMPD4 RAPGEF4 ADGRB3 SRGAP3 ROBO1 SRGAP2B IGSF21 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 7.05e-07 | 685 | 110 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | synapse assembly | ADGRB3 SRGAP3 ROBO1 SRGAP2B CAPRIN1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 7.91e-07 | 308 | 110 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.12e-06 | 35 | 110 | 5 | GO:0007214 | |
| GeneOntologyBiologicalProcess | cell junction organization | LGMN FRMPD4 RAPGEF4 ADGRB3 SRGAP3 ROBO1 MACF1 SRGAP2B IGSF21 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 1.54e-05 | 974 | 110 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 4.73e-05 | 74 | 110 | 5 | GO:0051932 | |
| GeneOntologyBiologicalProcess | cell junction assembly | ADGRB3 SRGAP3 ROBO1 MACF1 SRGAP2B CAPRIN1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 5.21e-05 | 569 | 110 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | FZD3 ADGRB3 POU4F2 ASPM ROBO1 MACF1 PLAG1 CAPRIN1 EPHA4 EPHB1 | 8.11e-05 | 418 | 110 | 10 | GO:0051962 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.54e-04 | 150 | 110 | 6 | GO:0050773 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 4.04e-08 | 19 | 110 | 5 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 7.00e-08 | 21 | 110 | 5 | GO:1902710 | |
| GeneOntologyCellularComponent | leading edge membrane | KSR1 ROBO1 MACF1 ARHGEF4 ARHGAP45 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.65e-07 | 210 | 110 | 10 | GO:0031256 |
| GeneOntologyCellularComponent | postsynaptic specialization | FRMPD4 RAPGEF4 ADGRB3 CRTC1 SYN2 MACF1 IGSF21 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 | 2.46e-06 | 503 | 110 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | neuron projection membrane | 4.68e-06 | 82 | 110 | 6 | GO:0032589 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.13e-05 | 201 | 110 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | dendrite membrane | 1.14e-05 | 56 | 110 | 5 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.24e-05 | 57 | 110 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | cell projection membrane | KSR1 ROBO1 MACF1 ARHGEF4 EFCAB7 ARHGAP45 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.72e-05 | 431 | 110 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | cell leading edge | KSR1 ROBO1 MACF1 ARHGEF4 ARHGAP45 CAPRIN1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 6.64e-05 | 500 | 110 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.14e-05 | 17 | 110 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | dendrite | FRMPD4 FZD3 RAPGEF4 CRTC1 CNNM1 ROBO1 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 1.64e-04 | 858 | 110 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FRMPD4 FZD3 RAPGEF4 CRTC1 CNNM1 ROBO1 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 1.68e-04 | 860 | 110 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | integrator complex | 1.76e-04 | 21 | 110 | 3 | GO:0032039 | |
| GeneOntologyCellularComponent | postsynapse | FRMPD4 RAPGEF4 ADGRB3 CRTC1 SRGAP3 SYN2 MACF1 IGSF21 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 | 2.86e-04 | 1018 | 110 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | glutamatergic synapse | FRMPD4 FZD3 RAPGEF4 ADGRB3 CRTC1 ATP8A1 SRGAP3 SCN2A SYN2 SRGAP2B CAPRIN1 EPHA4 EPHB1 | 3.63e-04 | 817 | 110 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | sodium channel complex | 4.69e-04 | 29 | 110 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | presynaptic membrane | 6.62e-04 | 277 | 110 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 8.76e-04 | 378 | 110 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | synaptic membrane | FZD3 ADGRB3 SCN2A IGSF21 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 | 1.02e-03 | 583 | 110 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | inner dynein arm | 1.20e-03 | 10 | 110 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.36e-03 | 405 | 110 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.76e-03 | 164 | 110 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | transporter complex | 2.50e-03 | 550 | 110 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.56e-03 | 108 | 110 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.66e-03 | 451 | 110 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.73e-03 | 477 | 110 | 8 | GO:0032279 | |
| HumanPheno | Epilepsia partialis continua | 1.25e-06 | 12 | 38 | 4 | HP:0012847 | |
| HumanPheno | Dysgenesis of the hippocampus | 4.50e-06 | 16 | 38 | 4 | HP:0025101 | |
| HumanPheno | Focal motor status epilepticus | 5.85e-06 | 17 | 38 | 4 | HP:0032663 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.09e-05 | 8 | 38 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.09e-05 | 8 | 38 | 3 | HP:0200048 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 4.09e-05 | 27 | 38 | 4 | HP:0031475 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 5.47e-05 | 29 | 38 | 4 | HP:0032658 | |
| HumanPheno | Limited neck range of motion | 6.07e-05 | 11 | 38 | 3 | HP:0000466 | |
| HumanPheno | Progressive gait ataxia | 6.28e-05 | 30 | 38 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 6.28e-05 | 30 | 38 | 4 | HP:0001329 | |
| HumanPheno | Cogwheel rigidity | 8.15e-05 | 32 | 38 | 4 | HP:0002396 | |
| HumanPheno | Obsessive-compulsive trait | 9.23e-05 | 33 | 38 | 4 | HP:0008770 | |
| HumanPheno | Limitation of neck motion | 1.31e-04 | 36 | 38 | 4 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 1.31e-04 | 36 | 38 | 4 | HP:0025669 | |
| HumanPheno | Facial tics | 1.64e-04 | 15 | 38 | 3 | HP:0011468 | |
| HumanPheno | Second degree atrioventricular block | 1.64e-04 | 15 | 38 | 3 | HP:0011706 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.64e-04 | 15 | 38 | 3 | HP:0007207 | |
| HumanPheno | Complex febrile seizure | 2.01e-04 | 16 | 38 | 3 | HP:0011172 | |
| HumanPheno | Visually-induced seizure | 2.89e-04 | 18 | 38 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.89e-04 | 18 | 38 | 3 | HP:0032860 | |
| HumanPheno | Disordered formal thought process | NAT8L NSD2 POLG HUWE1 ASXL3 SCN2A SCN9A MACF1 SLC45A1 GABRA1 | 3.82e-04 | 386 | 38 | 10 | HP:0025769 |
| HumanPheno | Non-convulsive status epilepticus without coma | 4.00e-04 | 20 | 38 | 3 | HP:0032671 | |
| HumanPheno | Abnormal hippocampus morphology | 4.05e-04 | 48 | 38 | 4 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 4.39e-04 | 49 | 38 | 4 | HP:0007343 | |
| HumanPheno | Allodynia | 5.34e-04 | 5 | 38 | 2 | HP:0012533 | |
| HumanPheno | Reflex seizure | 5.35e-04 | 22 | 38 | 3 | HP:0020207 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 5.52e-04 | 52 | 38 | 4 | HP:0025190 | |
| MousePheno | abnormal GABA-mediated receptor currents | 6.68e-08 | 18 | 87 | 5 | MP:0004008 | |
| MousePheno | shortened circadian behavior period | 1.88e-05 | 26 | 87 | 4 | MP:0020470 | |
| MousePheno | abnormal circadian behavior period | 7.08e-05 | 36 | 87 | 4 | MP:0020468 | |
| MousePheno | abnormal CNS synaptic transmission | LGMN FZD3 PPARA ADCYAP1R1 KSR1 SRGAP3 SCN2A SCN9A SYN2 IGSF21 CAPRIN1 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 | 1.02e-04 | 985 | 87 | 17 | MP:0002206 |
| Domain | GABAAa_rcpt | 3.35e-11 | 6 | 107 | 5 | IPR001390 | |
| Domain | GABAA/Glycine_rcpt | 1.74e-07 | 23 | 107 | 5 | IPR006028 | |
| Domain | Na_trans_cytopl | 3.61e-06 | 6 | 107 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 3.61e-06 | 6 | 107 | 3 | IPR024583 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.72e-06 | 45 | 107 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 6.39e-06 | 46 | 107 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 7.12e-06 | 47 | 107 | 5 | IPR006029 | |
| Domain | - | 7.12e-06 | 47 | 107 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 7.12e-06 | 47 | 107 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 7.12e-06 | 47 | 107 | 5 | PS00236 | |
| Domain | Neur_channel | 7.12e-06 | 47 | 107 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.12e-06 | 47 | 107 | 5 | IPR006202 | |
| Domain | Na_channel_asu | 2.13e-05 | 10 | 107 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.13e-05 | 10 | 107 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.13e-05 | 10 | 107 | 3 | PF06512 | |
| Domain | IQ | 1.02e-04 | 81 | 107 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.68e-04 | 90 | 107 | 5 | IPR000048 | |
| Domain | IQ | 1.96e-04 | 93 | 107 | 5 | PS50096 | |
| Domain | FCH | 2.60e-04 | 22 | 107 | 3 | SM00055 | |
| Domain | FCH_dom | 2.98e-04 | 23 | 107 | 3 | IPR001060 | |
| Domain | F_BAR | 3.84e-04 | 25 | 107 | 3 | IPR031160 | |
| Domain | F_BAR | 3.84e-04 | 25 | 107 | 3 | PS51741 | |
| Domain | IGv | 9.05e-04 | 75 | 107 | 4 | SM00406 | |
| Domain | - | ADAMTSL3 BTN3A2 BTN3A1 BTN3A3 NFATC2 ROBO1 OSMR IGSF21 ANKFN1 EPHA4 EPHB1 | 1.47e-03 | 663 | 107 | 11 | 2.60.40.10 |
| Domain | Ig-like_fold | ADAMTSL3 BTN3A2 BTN3A1 BTN3A3 NFATC2 ROBO1 OSMR IGSF21 ANKFN1 EPHA4 EPHB1 | 2.40e-03 | 706 | 107 | 11 | IPR013783 |
| Domain | fn3 | 2.41e-03 | 162 | 107 | 5 | PF00041 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.83e-03 | 14 | 107 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.83e-03 | 14 | 107 | 2 | PS00790 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.83e-03 | 14 | 107 | 2 | IPR024317 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.83e-03 | 14 | 107 | 2 | IPR001426 | |
| Domain | Dynein_HC_stalk | 2.83e-03 | 14 | 107 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.83e-03 | 14 | 107 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.83e-03 | 14 | 107 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.83e-03 | 14 | 107 | 2 | IPR011704 | |
| Domain | EphA2_TM | 2.83e-03 | 14 | 107 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.83e-03 | 14 | 107 | 2 | IPR001090 | |
| Domain | Eph_TM | 2.83e-03 | 14 | 107 | 2 | IPR027936 | |
| Domain | EPH_lbd | 2.83e-03 | 14 | 107 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 2.83e-03 | 14 | 107 | 2 | PF01404 | |
| Domain | MT | 2.83e-03 | 14 | 107 | 2 | PF12777 | |
| Domain | AAA_8 | 2.83e-03 | 14 | 107 | 2 | PF12780 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.83e-03 | 14 | 107 | 2 | IPR016257 | |
| Domain | EPH_LBD | 2.83e-03 | 14 | 107 | 2 | PS51550 | |
| Domain | AAA_5 | 2.83e-03 | 14 | 107 | 2 | PF07728 | |
| Domain | DHC_fam | 3.25e-03 | 15 | 107 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.25e-03 | 15 | 107 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.25e-03 | 15 | 107 | 2 | IPR004273 | |
| Domain | ARM-type_fold | 3.38e-03 | 339 | 107 | 7 | IPR016024 | |
| Domain | FN3 | 4.25e-03 | 185 | 107 | 5 | SM00060 | |
| Domain | Channel_four-helix_dom | 4.27e-03 | 57 | 107 | 3 | IPR027359 | |
| Domain | - | 4.27e-03 | 57 | 107 | 3 | 1.20.120.350 | |
| Domain | GPCR_2_secretin-like | 4.94e-03 | 60 | 107 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.94e-03 | 60 | 107 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.17e-03 | 61 | 107 | 3 | PS50261 | |
| Domain | Myosin-like_IQ_dom | 5.22e-03 | 19 | 107 | 2 | IPR027401 | |
| Domain | - | 5.22e-03 | 19 | 107 | 2 | 4.10.270.10 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.11e-09 | 9 | 89 | 5 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.20e-09 | 10 | 89 | 5 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.20e-09 | 10 | 89 | 5 | MM1401 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.34e-06 | 31 | 89 | 5 | M39369 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 3.81e-06 | 38 | 89 | 5 | M39854 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.72e-05 | 60 | 89 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.72e-05 | 60 | 89 | 5 | M976 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 5.14e-05 | 12 | 89 | 3 | M27738 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.51e-05 | 211 | 89 | 8 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.96e-04 | 144 | 89 | 6 | MM14501 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.02e-04 | 270 | 89 | 8 | M15514 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.06e-04 | 367 | 89 | 9 | M48346 | |
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 20457185 | ||
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 25865415 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 1.51e-10 | 11 | 113 | 5 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 1.51e-10 | 11 | 113 | 5 | 38894703 | |
| Pubmed | 4.17e-10 | 13 | 113 | 5 | 22569571 | ||
| Pubmed | 4.17e-10 | 13 | 113 | 5 | 22640814 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 5.27e-10 | 5 | 113 | 4 | 30104684 | |
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.58e-09 | 6 | 113 | 4 | 15033447 | |
| Pubmed | 2.74e-09 | 18 | 113 | 5 | 19078961 | ||
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 3.67e-09 | 7 | 113 | 4 | 20843900 | |
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 35228700 | ||
| Pubmed | 6.46e-09 | 21 | 113 | 5 | 25708312 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 8175718 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 7.32e-09 | 8 | 113 | 4 | 18185516 | |
| Pubmed | 2.19e-08 | 10 | 113 | 4 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 2.19e-08 | 10 | 113 | 4 | 21789198 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 15017002 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 16835366 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 15304513 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 1356407 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 22767497 | ||
| Pubmed | 1.03e-07 | 14 | 113 | 4 | 22768092 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 26518133 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 1.33e-07 | 4 | 113 | 3 | 39142074 | |
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 25080596 | ||
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 1.33e-07 | 4 | 113 | 3 | 20692323 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.33e-07 | 4 | 113 | 3 | 18821008 | |
| Pubmed | 2.74e-07 | 81 | 113 | 6 | 22723691 | ||
| Pubmed | 3.12e-07 | 18 | 113 | 4 | 18985723 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 29339503 | ||
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 21751815 | ||
| Pubmed | PPP4R1 ZCCHC8 POLG RAPGEF4 ADGRB3 CUL9 NCBP1 NCAPH2 STAM HUWE1 CRYL1 KHDRBS1 ZBTB5 ROBO1 MACF1 LRBA CAPRIN1 | 8.93e-07 | 1285 | 113 | 17 | 35914814 | |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 16080114 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 17021187 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 16101898 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 1.16e-06 | 7 | 113 | 3 | 11170752 | |
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 11528422 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 16382098 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | NAT8L ZCCHC8 NCBP1 KHDRBS1 ASPM INTS9 NDUFAF6 CAPRIN1 GABRA1 GABRA4 | 2.85e-06 | 462 | 113 | 10 | 31138677 |
| Pubmed | 3.91e-06 | 197 | 113 | 7 | 36604605 | ||
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 7.19e-06 | 12 | 113 | 3 | 2561974 | |
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 15123669 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11378843 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22763624 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23147414 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23109109 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22666188 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27155990 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8391122 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18973555 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31056671 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 32778883 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 1.05e-05 | 2 | 113 | 2 | 18202657 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 36469977 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26446222 | ||
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 1.05e-05 | 2 | 113 | 2 | 16847056 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9655866 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 1.05e-05 | 2 | 113 | 2 | 11021797 | |
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 1.05e-05 | 2 | 113 | 2 | 21918970 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22846996 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19457072 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26861708 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18085262 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 36933792 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24553732 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21073549 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 1.05e-05 | 2 | 113 | 2 | 15341600 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21056629 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21113407 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19207358 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16253225 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23067879 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 1.05e-05 | 2 | 113 | 2 | 26973458 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NSD2 POLG MAML1 CUL9 PPARA HUWE1 LARS2 BTN3A2 MICALL1 SCN5A NLRC5 ARHGEF4 SLC45A1 LRBA | 1.45e-05 | 1105 | 113 | 14 | 35748872 |
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 2.63e-05 | 18 | 113 | 3 | 9149941 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19284629 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 25578728 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29655203 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29331071 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 34474167 | ||
| Pubmed | Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. | 3.13e-05 | 3 | 113 | 2 | 16770606 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 27128218 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 7609620 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29961870 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29135068 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 32376074 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35230972 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24027285 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 34584155 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18063661 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15316014 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18482426 | ||
| Pubmed | GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. | 3.13e-05 | 3 | 113 | 2 | 18818659 | |
| Pubmed | Modulation of GABAA receptor signaling increases neurogenesis and suppresses anxiety through NFATc4. | 3.13e-05 | 3 | 113 | 2 | 24948817 | |
| Pubmed | Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. | 3.13e-05 | 3 | 113 | 2 | 21722213 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 20038812 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29023704 | ||
| Interaction | GABRA5 interactions | 1.44e-06 | 5 | 107 | 3 | int:GABRA5 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.00e-08 | 19 | 83 | 5 | 563 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.68e-06 | 9 | 83 | 3 | 1203 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 4.08e-05 | 15 | 83 | 3 | 458 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.55e-04 | 23 | 83 | 3 | 1288 | |
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 83 | 5 | 555 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.83e-03 | 14 | 83 | 2 | 1095 | |
| GeneFamily | Integrator complex | 2.10e-03 | 15 | 83 | 2 | 1366 | |
| GeneFamily | Dyneins, axonemal | 2.71e-03 | 17 | 83 | 2 | 536 | |
| Coexpression | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 | 1.73e-06 | 47 | 112 | 5 | M1652 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.27e-05 | 180 | 112 | 7 | M8239 | |
| CoexpressionAtlas | BM Top 100 - frontal lobe | 8.12e-08 | 72 | 108 | 7 | BM Top 100 - frontal lobe | |
| CoexpressionAtlas | BM Top 100 - temporal lobe | 9.84e-08 | 74 | 108 | 7 | BM Top 100 - temporal lobe | |
| CoexpressionAtlas | BM Top 100 - amygdala | 1.94e-06 | 73 | 108 | 6 | BM Top 100 - amygdala | |
| CoexpressionAtlas | cerebral cortex | NAT8L SCHIP1 FRMPD4 RAPGEF4 ADGRB3 ADCYAP1R1 ARFGEF3 CNNM1 SRGAP3 SCN2A SYN2 PLPP4 ARHGEF4 SLC45A1 IGSF21 GABRA1 EPHA4 GABRA2 GABRA3 GABRA4 GABRA5 EPHB1 | 2.49e-06 | 1428 | 108 | 22 | cerebral cortex |
| CoexpressionAtlas | BM Top 100 - hippocampus | 2.87e-06 | 78 | 108 | 6 | BM Top 100 - hippocampus | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | CA12 LGMN SCHIP1 GBP7 FZD3 ST8SIA1 HUWE1 ATP8A1 KHDRBS1 ASXL3 OSMR VEGFD EPHA4 GABRA4 EPHB1 | 2.16e-05 | 836 | 108 | 15 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 3.54e-05 | 73 | 108 | 5 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.22e-05 | 250 | 108 | 8 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | ST8SIA1 HUWE1 FIGN ATP8A1 KHDRBS1 ASXL3 OSMR VEGFD MBNL3 GABRA1 | 5.80e-05 | 421 | 108 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | RAPGEF4 ADGRB3 ST8SIA1 HUWE1 ATP8A1 ASXL3 ASPM SYN2 ROBO1 PLAG1 CAPRIN1 GABRA1 EPHA4 GABRA3 | 6.90e-05 | 818 | 108 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | CA12 LGMN ADGRB3 ST8SIA1 HUWE1 INTS3 KHDRBS1 ASXL3 SCN2A OSMR VEGFD GABRA1 GABRA4 EPHB1 | 1.10e-04 | 855 | 108 | 14 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-04 | 97 | 108 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 1.83e-04 | 103 | 108 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | ETV3 NCBP1 HUWE1 FIGN KHDRBS1 OGFOD1 ROBO1 ZFHX3 EPHA4 GABRA4 | 2.07e-04 | 492 | 108 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 2.71e-04 | 415 | 108 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 2.86e-04 | 249 | 108 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | RNF213 ST8SIA1 PPP2R3A KHDRBS1 SRGAP3 ASXL3 SCN2A ASPM ROBO1 PLAG1 VEGFD MBNL3 GABRA4 | 3.07e-04 | 831 | 108 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 3.58e-04 | 431 | 108 | 9 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | ETV3 NCBP1 STAM HUWE1 FIGN KHDRBS1 ASXL3 OGFOD1 ROBO1 ZFHX3 GABRA1 EPHA4 GABRA4 | 3.81e-04 | 850 | 108 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.48e-04 | 125 | 108 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_500 | 4.48e-04 | 70 | 108 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.63e-04 | 193 | 108 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 4.99e-04 | 72 | 108 | 4 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | PPP4R1 LGMN SCHIP1 FZD3 RAPGEF4 RNF213 ST8SIA1 CRYL1 ATP8A1 SRGAP3 ROBO1 PLCB2 ARHGEF4 | 5.28e-04 | 880 | 108 | 13 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_100 | 5.29e-04 | 7 | 108 | 2 | gudmap_kidney_adult_RenalCapsule_k3_100 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.89e-08 | 196 | 113 | 8 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.05e-08 | 197 | 113 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.38e-08 | 199 | 113 | 8 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-07 | 177 | 113 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-07 | 177 | 113 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 3.52e-07 | 177 | 113 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-07 | 177 | 113 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.52e-07 | 177 | 113 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.09e-07 | 181 | 113 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-07 | 184 | 113 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-07 | 184 | 113 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-07 | 184 | 113 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.92e-07 | 186 | 113 | 7 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.10e-07 | 187 | 113 | 7 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.29e-07 | 188 | 113 | 7 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.68e-07 | 190 | 113 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 5.88e-07 | 191 | 113 | 7 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | MNPs-Dendritic_Cells|MNPs / lung cells shred on cell class, cell subclass, sample id | 6.31e-07 | 193 | 113 | 7 | 0e6b8e179bfe1c6e93137c76c76a91c7782a4989 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.31e-07 | 193 | 113 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.31e-07 | 193 | 113 | 7 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.49e-07 | 198 | 113 | 7 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.49e-07 | 198 | 113 | 7 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.74e-07 | 199 | 113 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.74e-07 | 199 | 113 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.01e-07 | 200 | 113 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 134 | 113 | 6 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 2.25e-06 | 149 | 113 | 6 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.94e-06 | 156 | 113 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 4.20e-06 | 166 | 113 | 6 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 4.35e-06 | 167 | 113 | 6 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.50e-06 | 168 | 113 | 6 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.66e-06 | 169 | 113 | 6 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.66e-06 | 169 | 113 | 6 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 5.88e-06 | 176 | 113 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-06 | 179 | 113 | 6 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 180 | 113 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.12e-06 | 182 | 113 | 6 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.12e-06 | 182 | 113 | 6 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-06 | 185 | 113 | 6 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.82e-06 | 185 | 113 | 6 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 7.82e-06 | 185 | 113 | 6 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-06 | 186 | 113 | 6 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-06 | 186 | 113 | 6 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-06 | 187 | 113 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-06 | 187 | 113 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-06 | 187 | 113 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 8.31e-06 | 187 | 113 | 6 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-06 | 187 | 113 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 8.57e-06 | 188 | 113 | 6 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.57e-06 | 188 | 113 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 8.57e-06 | 188 | 113 | 6 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 8.57e-06 | 188 | 113 | 6 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 9.10e-06 | 190 | 113 | 6 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 9.10e-06 | 190 | 113 | 6 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 9.38e-06 | 191 | 113 | 6 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.38e-06 | 191 | 113 | 6 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 9.38e-06 | 191 | 113 | 6 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.38e-06 | 191 | 113 | 6 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 9.38e-06 | 191 | 113 | 6 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 192 | 113 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 9.66e-06 | 192 | 113 | 6 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.95e-06 | 193 | 113 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 194 | 113 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 1.06e-05 | 195 | 113 | 6 | b748cb15846345363e8c2ee5936bb42bba3ba9a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 195 | 113 | 6 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.06e-05 | 195 | 113 | 6 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.09e-05 | 196 | 113 | 6 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 196 | 113 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-05 | 196 | 113 | 6 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 196 | 113 | 6 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.09e-05 | 196 | 113 | 6 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 196 | 113 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 196 | 113 | 6 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 196 | 113 | 6 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.12e-05 | 197 | 113 | 6 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.12e-05 | 197 | 113 | 6 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 198 | 113 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 198 | 113 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 198 | 113 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 1.18e-05 | 199 | 113 | 6 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 1.22e-05 | 200 | 113 | 6 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.22e-05 | 200 | 113 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.53e-05 | 136 | 113 | 5 | 9d7080f695de4ef183e3dbdc18ba464a3b8e3469 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 137 | 113 | 5 | 48c21e6938a46e3cd74ac10b8ace0a4751741af7 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.18e-05 | 151 | 113 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 152 | 113 | 5 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-05 | 154 | 113 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-05 | 154 | 113 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.59e-05 | 154 | 113 | 5 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 155 | 113 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 155 | 113 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 4.88e-05 | 156 | 113 | 5 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.88e-05 | 156 | 113 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Endothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.41e-05 | 81 | 113 | 4 | a1193b2cfb84a6b6593779fef5f54a61567a12d7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-05 | 160 | 113 | 5 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 5.50e-05 | 160 | 113 | 5 | 9f7f24a52a24fb926df69c8e5aad64ee75a66ef1 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 160 | 113 | 5 | 85205dc68369d3e04df3460c1f3861ee2dc242a9 | |
| Computational | Neighborhood of CASP8 | 3.22e-05 | 27 | 74 | 4 | GNF2_CASP8 | |
| Computational | Genes in the cancer module 141. | 1.64e-04 | 16 | 74 | 3 | MODULE_141 | |
| Drug | Meprobamate | 1.57e-11 | 6 | 112 | 5 | DB00371 | |
| Drug | Ethchlorvynol | 3.27e-10 | 9 | 112 | 5 | DB00189 | |
| Drug | Flumazenil | 5.55e-10 | 4 | 112 | 4 | DB01205 | |
| Drug | Secobarbital | 6.50e-10 | 10 | 112 | 5 | DB00418 | |
| Drug | Chlordiazepoxide | 6.50e-10 | 10 | 112 | 5 | DB00475 | |
| Drug | Metharbital | 6.50e-10 | 10 | 112 | 5 | DB00463 | |
| Drug | Pentobarbital | 6.50e-10 | 10 | 112 | 5 | DB00312 | |
| Drug | Talbutal | 6.50e-10 | 10 | 112 | 5 | DB00306 | |
| Drug | Clobazam | 6.50e-10 | 10 | 112 | 5 | DB00349 | |
| Drug | Butalbital | 6.50e-10 | 10 | 112 | 5 | DB00241 | |
| Drug | Butabarbital | 6.50e-10 | 10 | 112 | 5 | DB00237 | |
| Drug | Bromazepam | 6.50e-10 | 10 | 112 | 5 | DB01558 | |
| Drug | Barbituric acid derivative | 6.50e-10 | 10 | 112 | 5 | DB01496 | |
| Drug | Barbital | 6.50e-10 | 10 | 112 | 5 | DB01483 | |
| Drug | Hexobarbital | 6.50e-10 | 10 | 112 | 5 | DB01355 | |
| Drug | Aprobarbital | 6.50e-10 | 10 | 112 | 5 | DB01352 | |
| Drug | Amobarbital | 6.50e-10 | 10 | 112 | 5 | DB01351 | |
| Drug | Heptabarbital | 6.50e-10 | 10 | 112 | 5 | DB01354 | |
| Drug | Butethal | 6.50e-10 | 10 | 112 | 5 | DB01353 | |
| Drug | Methylphenobarbital | 6.50e-10 | 10 | 112 | 5 | DB00849 | |
| Drug | Oxazepam | 6.50e-10 | 10 | 112 | 5 | DB00842 | |
| Drug | Primidone | 6.50e-10 | 10 | 112 | 5 | DB00794 | |
| Drug | Midazolam | 6.50e-10 | 10 | 112 | 5 | DB00683 | |
| Drug | Flurazepam | 6.50e-10 | 10 | 112 | 5 | DB00690 | |
| Drug | Clonazepam | 6.50e-10 | 10 | 112 | 5 | DB01068 | |
| Drug | Thiopental | 1.19e-09 | 11 | 112 | 5 | DB00599 | |
| Drug | Alprazolam | 1.19e-09 | 11 | 112 | 5 | DB00404 | |
| Drug | Temazepam | 1.19e-09 | 11 | 112 | 5 | DB00231 | |
| Drug | Nitrazepam | 1.19e-09 | 11 | 112 | 5 | DB01595 | |
| Drug | Lorazepam | 1.19e-09 | 11 | 112 | 5 | DB00186 | |
| Drug | Phenobarbital | 1.19e-09 | 11 | 112 | 5 | DB01174 | |
| Drug | Triazolam | 1.19e-09 | 11 | 112 | 5 | DB00897 | |
| Drug | Clorazepate | 1.19e-09 | 11 | 112 | 5 | DB00628 | |
| Drug | Eszopiclone | 2.76e-09 | 5 | 112 | 4 | DB00402 | |
| Drug | Zopiclone | 2.76e-09 | 5 | 112 | 4 | DB01198 | |
| Drug | Lorazepam | 2.76e-09 | 5 | 112 | 4 | ctd:D008140 | |
| Drug | 3-isothujone | 6.68e-09 | 30 | 112 | 6 | CID000011027 | |
| Drug | Flunitrazepam | 8.26e-09 | 6 | 112 | 4 | DB01544 | |
| Drug | dihydroxyaflavinine | 1.55e-08 | 17 | 112 | 5 | CID000156857 | |
| Drug | Quazepam | 1.92e-08 | 7 | 112 | 4 | DB01589 | |
| Drug | gamma-Aminobutyric Acid | 2.27e-08 | 62 | 112 | 7 | ctd:D005680 | |
| Drug | zaleplon | 3.54e-08 | 39 | 112 | 6 | CID000005719 | |
| Drug | Adinazolam | 3.83e-08 | 8 | 112 | 4 | DB00546 | |
| Drug | Fludiazepam | 3.83e-08 | 8 | 112 | 4 | DB01567 | |
| Drug | Clotiazepam | 3.83e-08 | 8 | 112 | 4 | DB01559 | |
| Drug | Cinolazepam | 3.83e-08 | 8 | 112 | 4 | DB01594 | |
| Drug | Prazepam | 3.83e-08 | 8 | 112 | 4 | DB01588 | |
| Drug | Estazolam | 3.83e-08 | 8 | 112 | 4 | DB01215 | |
| Drug | Halazepam | 3.83e-08 | 8 | 112 | 4 | DB00801 | |
| Drug | zolpidem | 6.51e-08 | 43 | 112 | 6 | CID000005732 | |
| Drug | Diazepam | 6.86e-08 | 9 | 112 | 4 | DB00829 | |
| Drug | thymol | 9.88e-08 | 46 | 112 | 6 | CID000006989 | |
| Drug | heptachlor epoxide | 9.88e-08 | 46 | 112 | 6 | CID000013930 | |
| Drug | methohexital | 1.04e-07 | 24 | 112 | 5 | CID000009034 | |
| Drug | AC1L1FKW | 1.14e-07 | 10 | 112 | 4 | CID000003281 | |
| Drug | Zolpidem | 1.16e-07 | 3 | 112 | 3 | DB00425 | |
| Drug | isonipecotic acid | 1.29e-07 | 25 | 112 | 5 | CID000003773 | |
| Drug | fosazepam | 1.78e-07 | 11 | 112 | 4 | CID000037114 | |
| Drug | C19H18ClN3O | 1.78e-07 | 11 | 112 | 4 | CID000027452 | |
| Drug | flutoprazepam | 1.78e-07 | 11 | 112 | 4 | CID000003400 | |
| Drug | Arfendazam | 1.78e-07 | 11 | 112 | 4 | CID000065803 | |
| Drug | camazepam | 1.78e-07 | 11 | 112 | 4 | CID000037367 | |
| Drug | Bu-1014 | 1.78e-07 | 11 | 112 | 4 | CID015942721 | |
| Drug | Zapizolam | 1.78e-07 | 11 | 112 | 4 | CID000068832 | |
| Drug | Reclazepam | 1.78e-07 | 11 | 112 | 4 | CID003052777 | |
| Drug | iclazepam | 1.78e-07 | 11 | 112 | 4 | CID000068777 | |
| Drug | menitrazepam | 1.78e-07 | 11 | 112 | 4 | CID000189875 | |
| Drug | Serin hydrazid | 1.78e-07 | 11 | 112 | 4 | CID000041637 | |
| Drug | sulazepam | 1.78e-07 | 11 | 112 | 4 | CID000017931 | |
| Drug | elfazepam | 1.78e-07 | 11 | 112 | 4 | CID000065445 | |
| Drug | triflubazam | 1.78e-07 | 11 | 112 | 4 | CID000031157 | |
| Drug | uldazepam | 1.78e-07 | 11 | 112 | 4 | CID000034274 | |
| Drug | gidazepam | 1.78e-07 | 11 | 112 | 4 | CID000121919 | |
| Drug | fletazepam | 1.78e-07 | 11 | 112 | 4 | CID000036834 | |
| Drug | SB-205384 | 2.66e-07 | 12 | 112 | 4 | CID000197690 | |
| Drug | U-93631 | 2.66e-07 | 12 | 112 | 4 | CID000197626 | |
| Drug | haloxazolam | 2.66e-07 | 12 | 112 | 4 | CID000003563 | |
| Drug | doxefazepam | 2.66e-07 | 12 | 112 | 4 | CID000038668 | |
| Drug | pivoxazepam | 2.66e-07 | 12 | 112 | 4 | CID000068722 | |
| Drug | razobazam | 2.66e-07 | 12 | 112 | 4 | CID000071228 | |
| Drug | allylglycine | 3.40e-07 | 30 | 112 | 5 | CID000014044 | |
| Drug | nerisopam | 3.83e-07 | 13 | 112 | 4 | CID000065875 | |
| Drug | flutazolam | 3.83e-07 | 13 | 112 | 4 | CID000003398 | |
| Drug | 4-PIOL | 3.83e-07 | 13 | 112 | 4 | CID000125520 | |
| Drug | AC1MVFYM | 3.83e-07 | 13 | 112 | 4 | CID003707225 | |
| Drug | Ro 11-3128 | 3.83e-07 | 13 | 112 | 4 | CID000093364 | |
| Drug | cinolazepam | 3.83e-07 | 13 | 112 | 4 | CID003033621 | |
| Drug | alpha IMGBL | 3.83e-07 | 13 | 112 | 4 | CID000131516 | |
| Drug | metaclazepam | 3.83e-07 | 13 | 112 | 4 | CID000071272 | |
| Drug | flunitrazepam | 4.51e-07 | 59 | 112 | 6 | CID000003380 | |
| Drug | etizolam | 4.62e-07 | 4 | 112 | 3 | ctd:C044610 | |
| Drug | AC1L1BIT | 4.99e-07 | 60 | 112 | 6 | CID000001457 | |
| Drug | 5 beta-pregnanediol | 4.99e-07 | 60 | 112 | 6 | CID000012547 | |
| Drug | beta-CCt | 5.35e-07 | 14 | 112 | 4 | CID000124514 | |
| Drug | Me-lex | 5.35e-07 | 14 | 112 | 4 | CID000004177 | |
| Drug | ethyl loflazepate | 5.35e-07 | 14 | 112 | 4 | CID000003299 | |
| Drug | CGS 8216 | 5.60e-07 | 33 | 112 | 5 | CID000104916 | |
| Drug | AC1L2FYN | 5.60e-07 | 33 | 112 | 5 | CID000071333 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; PC3; HT_HG-U133A | 6.02e-07 | 198 | 112 | 9 | 2107_DN | |
| Drug | SR 95103 | 7.26e-07 | 15 | 112 | 4 | CID000125958 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.01e-06 | 10 | 104 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.01e-06 | 10 | 104 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.14e-06 | 12 | 104 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.19e-05 | 13 | 104 | 3 | C0751122 | |
| Disease | Autistic Disorder | 3.33e-04 | 261 | 104 | 6 | C0004352 | |
| Disease | aspartate aminotransferase measurement | DNAH2 ERVK13-1 RNF213 STAM CNNM1 NLRC5 ROBO1 PLAG1 LRBA ARHGAP45 IGSF21 | 3.51e-04 | 904 | 104 | 11 | EFO_0004736 |
| Disease | valine measurement | 3.82e-04 | 40 | 104 | 3 | EFO_0009792 | |
| Disease | mean arterial pressure | 3.94e-04 | 499 | 104 | 8 | EFO_0006340 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.36e-04 | 9 | 104 | 2 | C3502809 | |
| Disease | autistic disorder (is_implicated_in) | 4.42e-04 | 42 | 104 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Epilepsy | 6.10e-04 | 109 | 104 | 4 | C0014544 | |
| Disease | sitting height ratio | 7.83e-04 | 51 | 104 | 3 | EFO_0007118 | |
| Disease | autistic disorder (is_marker_for) | 7.94e-04 | 12 | 104 | 2 | DOID:12849 (is_marker_for) | |
| Disease | neuroticism measurement, cognitive function measurement | 8.97e-04 | 566 | 104 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | asthma, Eczema, allergic rhinitis | 9.02e-04 | 121 | 104 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.05e-03 | 447 | 104 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Schizophrenia | FZD3 PPARA LARS2 ADAMTSL3 ADCYAP1R1 SRGAP3 SYN2 GABRA1 GABRA4 GABRA5 | 1.13e-03 | 883 | 104 | 10 | C0036341 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.16e-03 | 222 | 104 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Tremor, Rubral | 1.43e-03 | 16 | 104 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.43e-03 | 16 | 104 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.43e-03 | 16 | 104 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 1.43e-03 | 16 | 104 | 2 | C0240991 | |
| Disease | Abnormal coordination | 1.43e-03 | 16 | 104 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.43e-03 | 16 | 104 | 2 | C0427190 | |
| Disease | cortical thickness | GLS2 FZD3 CUL9 ADAMTSL3 MICALL1 SRGAP3 ROBO1 MACF1 OSMR ANKFN1 EPHA4 | 1.90e-03 | 1113 | 104 | 11 | EFO_0004840 |
| Disease | cardiomyopathy (is_implicated_in) | 2.02e-03 | 19 | 104 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | executive function measurement | 2.19e-03 | 376 | 104 | 6 | EFO_0009332 | |
| Disease | leucine measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0009770 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 2.24e-03 | 20 | 104 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | Hematochezia, response to radiation | 2.24e-03 | 20 | 104 | 2 | GO_0009314, HP_0002573 | |
| Disease | Paroxysmal atrial fibrillation | 2.29e-03 | 156 | 104 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.29e-03 | 156 | 104 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.29e-03 | 156 | 104 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 2.51e-03 | 160 | 104 | 4 | C0004238 | |
| Disease | epilepsy (implicated_via_orthology) | 2.69e-03 | 163 | 104 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Mood Disorders | 3.00e-03 | 168 | 104 | 4 | C0525045 | |
| Disease | Epilepsy, Cryptogenic | 3.08e-03 | 82 | 104 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.08e-03 | 82 | 104 | 3 | C0751111 | |
| Disease | Aura | 3.08e-03 | 82 | 104 | 3 | C0236018 | |
| Disease | Ataxia | 3.50e-03 | 25 | 104 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LMDKPHSAPCLMSLS | 11 | A6NKX1 | |
| HALEMFPEHCTMPPD | 406 | Q86X53 | |
| GNIIMMPDAQTIECH | 216 | Q9NX77 | |
| PCHLFPTMSAETMEL | 51 | O00478 | |
| PCHLFPTMSAETMEL | 51 | O00481 | |
| LHMPMSMNELSNPCL | 1256 | O60242 | |
| MVPPLQCQMHPEEST | 326 | P41162 | |
| HMEPAQKPCFTTDMV | 21 | Q9NR80 | |
| MDMPQLVCPPVHSES | 401 | Q14444 | |
| PAMINHSDMSNTIPD | 1231 | Q8IZT6 | |
| HPTAPIICEFLTMMA | 471 | Q9Y2Q0 | |
| SCVMMNDVLETLPHI | 501 | Q9C0F0 | |
| PVEAPHCSEYKMQMA | 936 | Q99650 | |
| EMVKMVLSRPCHPDD | 856 | Q68E01 | |
| AQSHRMDLMIDCQPP | 481 | Q9NV88 | |
| PGVMDNPLVMHQLRC | 681 | P12883 | |
| PMDCPAALHQLMLDC | 846 | P54762 | |
| CPMAEFALPRHSAVM | 6 | Q92585 | |
| MDMDPFLHCVIPNFI | 56 | Q8N543 | |
| HPMVAESPSCLVATM | 711 | Q13469 | |
| EPREMAAMCLGLAHS | 131 | Q9Y2X3 | |
| HAMPATDLSAIMPSQ | 706 | Q5HY92 | |
| PNIIDHFLCDMDPLM | 181 | Q8NGC9 | |
| AHNCRQSVMQEPHMP | 321 | Q92619 | |
| NCHVIAAPSMVAMFE | 136 | Q09161 | |
| EPPAALVRDKMMECH | 316 | O75648 | |
| PMDCPIALHQLMLDC | 846 | P54764 | |
| KNSMPHTLDPMCDIA | 806 | Q5CZC0 | |
| TVQAECPMHLEDFPM | 161 | P47869 | |
| CPMHLEDFPMDAHSC | 166 | P47869 | |
| AFMQALMHAVDPEIP | 311 | Q9NR23 | |
| ALYCTHMDDPSPREM | 256 | O43570 | |
| HENVVLFMGACMNPP | 666 | Q8IVT5 | |
| HPDMMRLACADISIN | 181 | Q9H344 | |
| LPMDICMLHGVSQED | 231 | Q330K2 | |
| LMDKPHSAPCLMSLS | 11 | Q8IWN6 | |
| MLMFECHPQVCPAGE | 1036 | O96028 | |
| ERCPHPVTLAGMLEM | 416 | P54098 | |
| VALMSEHPNSMIPAF | 701 | P50851 | |
| LCMDSPSPMDPHMAE | 111 | P30305 | |
| DPNDMVSMSVPDCLS | 81 | Q8N3F8 | |
| MASEIHMPGPVCLTE | 1 | Q8N8V2 | |
| TIHAECPMHLEDFPM | 186 | P34903 | |
| CPMHLEDFPMDVHAC | 191 | P34903 | |
| TVRAECPMHLEDFPM | 161 | P14867 | |
| CPMHLEDFPMDAHAC | 166 | P14867 | |
| ECPMRLVDFPMDGHA | 171 | P48169 | |
| AECPMQLEDFPMDAH | 171 | P31644 | |
| MMCLSPPLDKLGNSH | 431 | Q9UI32 | |
| CIQAMIDPSMDPYPH | 366 | Q7Z6Z7 | |
| MGIEPLPFHDLLCQM | 1011 | Q06190 | |
| VMNSEMHCTGDPDLV | 121 | Q5VZY2 | |
| LPACLPAEAAMVHML | 351 | Q86WI3 | |
| NLKSICIPDVMPHMQ | 1921 | Q9UPN3 | |
| CIPDVMPHMQLADSA | 1926 | Q9UPN3 | |
| DHFPPIFMQAHECME | 141 | A6NCF6 | |
| ALLLLPMAPAMHSDC | 11 | P41586 | |
| PVVPHNECSEVMSNM | 366 | P04070 | |
| PRPEMQCPAEHEEDM | 41 | Q96BN8 | |
| FLTGNNEMIDMLPHC | 371 | A4D1B5 | |
| NEMIDMLPHCPLQSL | 376 | A4D1B5 | |
| SMLCLPMPSEHSLKQ | 2231 | Q9C0G6 | |
| CEVKHPALSMPMQAE | 321 | Q96ID5 | |
| PKSTMVCQHVMPLNE | 601 | A8K855 | |
| HMLNDPDMVLADPAT | 611 | Q6UUV9 | |
| QTEGMCPRMTVPALH | 1281 | Q14CM0 | |
| IQMHLDLENCMEEPP | 1916 | Q5TH69 | |
| PCHLFPTMSAETMEL | 51 | P78410 | |
| PDMCISFEVEPMEHT | 651 | Q8IY82 | |
| LCMAPASNIVPMMHG | 311 | Q9NUK0 | |
| PGVMHSSCPQEMAAV | 206 | O95372 | |
| QTAALAMEPFHPMVN | 56 | Q9NPG1 | |
| AMEPFHPMVNLDCSR | 61 | Q9NPG1 | |
| PPCEAYALMAHAMEE | 236 | Q07666 | |
| GALDLLMHMLCNPEP | 166 | Q8IWT3 | |
| NQDMCMKVPDDPEHL | 281 | Q9Y2S2 | |
| NLGSMACPIMEPLHL | 3031 | Q8NDH2 | |
| AEPMQLVCLMPTIHF | 4351 | Q9P225 | |
| NPSHAYMMDVCSPAD | 246 | Q9Y2W3 | |
| NPPFVIHDMETLCMA | 236 | Q07869 | |
| MLQVLQSCDHPGPDM | 346 | Q6ZN16 | |
| TLALKPMNCPAHCLM | 401 | Q9BW92 | |
| EVMDCSMPLIGEHQV | 386 | Q92777 | |
| MHCVFMPNTQLCPAL | 536 | Q8WZA2 | |
| CLPMDQFAVHLMPHL | 856 | Q8TF05 | |
| TMPICEEAGNMSHLE | 131 | Q9BXR5 | |
| LCALMVMAAPLAPHV | 781 | Q15031 | |
| ADLLPHMPHISECLM | 396 | P0DPB3 | |
| LPSHMGCMSDVDADP | 241 | Q12837 | |
| INMDLPMVSGDRIHC | 1836 | Q14524 | |
| MLPVNGKMHSAVDCN | 611 | Q15858 | |
| CDPAHLFAMTKMNSP | 86 | Q92185 | |
| PHMGDMASQLCAQQP | 346 | P0DMP2 | |
| ASSMLPVMALAPQEH | 371 | P46087 | |
| EHARAPEMPTNVCLM | 266 | Q8N957 | |
| MNTCVPHPRGAFMLE | 181 | Q6IBW4 | |
| TACHMDSSPQSPDME | 791 | Q9NRU3 | |
| LMEATLPGHRTMNPC | 76 | Q9UQ49 | |
| LPLGMTCPIDMDTVH | 311 | Q6DJT9 | |
| MPLELICSDEHMQGS | 3891 | Q63HN8 | |
| EHQMKDCPMPRNAAR | 236 | Q6NZY4 | |
| SHFVRPMQEVMGLPC | 476 | O15062 | |
| HTVMDMCNQVFCPPL | 316 | O43295 | |
| MPLPDTMFCAQQIHI | 1 | Q96C74 | |
| ELINMTGHCMPPNAL | 746 | Q9NXZ1 | |
| PILPMNGKMHSAVDC | 636 | Q99250 | |
| HLEAMCHQMGPLIDE | 331 | Q92783 | |
| LQPMLQDCPEETGHM | 1271 | Q9Y6N7 | |
| CLHSESNMPLTMPAL | 781 | Q00722 | |
| MVAKPPVMCSHFTQD | 71 | P17038 | |
| HLQEPALCGPHMMFD | 251 | O43915 | |
| CQAQAPIAAVLLMHM | 196 | Q9BXI6 | |
| MATELQCPDSMPCHN | 1 | Q96BW1 | |
| QDSPCIHPSEDSMDM | 161 | Q9HCK0 | |
| HAMTQHSVQPMLRCP | 1241 | Q15911 | |
| HSVQPMLRCPLCQDM | 1246 | Q15911 | |
| NDSLCDMVHRPPAMS | 681 | P82987 | |
| DMVHRPPAMSQACNT | 686 | P82987 | |
| ALHIMAMLHPEVCEP | 986 | P57678 | |
| IEACESGSMMNHLPD | 186 | Q99538 | |
| MHCGPPDMVCETKIV | 1 | Q8N9F0 |